Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001687014 | SCV001901311 | benign | not provided | 2021-03-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001687014 | SCV002410314 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458748 | SCV004179701 | benign | Developmental and epileptic encephalopathy, 69 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001687014 | SCV005282451 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003975958 | SCV004789954 | benign | CACNA1E-related disorder | 2023-11-30 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |